|
1
|
Tazawa H, Kagawa S and Fujiwara T:
Advances in adenovirus-mediated p53 cancer gene therapy. Expert
Opin Biol Ther. 13:1569–1583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu SX, Xia ZS and Zhong YQ: Gene therapy
in pancreatic cancer. World J Gastroenterol. 20:13343–13368. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Folkman J: Tumour angiogenesis:
therapeutic implications. N Engl J Med. 285:1182–1186. 1971.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hlatky L, Hahnfeldt P and Folkman J:
Clinical application of antiangiogenic therapy: microvessel
density, what it does and doesn’t tell us. J Natl Cancer Inst.
94:883–893. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Albig AR and Schiemann WP: Fibulin-5
antagonizes vascular endothelial growth factor (VEGF) signaling and
angiogenic sprouting by endothelial cells. DNA Cell Biol.
23:367–379. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sim BK: Angiostatin and endostatin:
endothelial cell-specific endogenous inhibitors of angiogenesis and
tumor growth. Angiogenesis. 2:37–48. 1998. View Article : Google Scholar
|
|
7
|
Ribatti D: History of research on
angiogenesis. Chem Immunol Allergy. 99:1–14. 2014. View Article : Google Scholar
|
|
8
|
Hamano Y, Zeisberg M, Sugimoto H, et al:
Physiological levels of tumstatin, a fragment of collagen IV alpha3
chain, are generated by MMP-9 proteolysis and suppress angiogenesis
via alphaVbeta3 integrin. Cancer Cell. 3:589–601. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Su XJ, Wu FJ, Yuan LJ and Lin XS:
Determination of anti-Hepg2 cells activity and purification of
tumor chalone T42 peptide. J Jilin Univ, Med Ed. 36:86–89.
2010.
|
|
10
|
Maeshima Y, Colorado PC, Torre A, et al:
Distinct antitumor properties of a type IV collagen domain derived
from basement membrane. J Biol Chem. 275:21340–21348. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maeshima Y, Manfredi M, Reimer C, et al:
Identification of the anti-angiogenic site within vascular basement
membrane-derived tumstatin. J Biol Chem. 276:15240–15248. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saus J, Wieslander J, Langeveld JP,
Quinones S and Hudson BG: Identification of the Goodpasture antigen
as the alpha 3(IV) chain of collagen IV. J Biol Chem.
263:13374–13380. 1988.PubMed/NCBI
|
|
13
|
Wang SJ, Liu XH, Ji YB and Chen N: Study
on Biological Activity of Two Modified Anti-tumor Peptide of
Tumstatin. Biochemistry and Biophysics. 34:1152–1161. 2007.(In
Chinese).
|
|
14
|
Gao Y, Yu Y, Lu S, Sun BC and Wang XH:
Cloning and expression of human tumstatin gene in E. Coli. Chinese
Journal of Biochemical Pharmaceutics. 26:324–327. 2005.(In
Chinese).
|
|
15
|
Li Y, Liu XH, Lin XS, et al: Inhibitory
effect of tumstatin related peptide T42 on human umbilical vein
endothelial cells and human gastric adenocarcinoma. J Clin Rehab
Tissue Engineer Res. 11:1837–1840. 2007.(In Chinese).
|
|
16
|
Su XJ, Lin XS, Wu FJ and Yuan LJ:
Antitumor activity of tumor chalone 42 peptide combined with
cyclophosphamide. China Cancer. 5:334–337. 2010.
|
|
17
|
Jones MS II, Harrach B, Ganac RD, et al:
New adenovirus species found in a patient presenting with
gastroenteritis. J Virol. 81:5978–5984. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bernt KM, Ni S, Tieu AT and Lieber A:
Assessment of a combined, adenovirus-mediated oncolytic and
immunostimulatory tumor therapy. Cancer Res. 65:4343–4352. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takehashi M, Kanatsu-Shinohara M, Inoue K,
et al: Adenovirus-mediated gene delivery into mouse spermatogonial
stem cells. Proc Natl Acad Sci USA. 104:2596–2601. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qi DD, Chen YL, Guo JZ, Zhu GM, Zhang T,
Jiang S and Wang YZ: Constructiong of recombinant adenovirus vector
with 4T42 peptide gene, and study of the effect of anti- SKBR3 cell
in vitro. Chinese Journal of Gerontology. 32:2781–2783. 2012.(In
Chinese).
|
|
21
|
Maeshima Y, Yerramalla UL, Dhanabal M, et
al: Extracellular matrix-derived peptide binds to alpha(v)beta(3)
integrin and inhibits angiogenesis. J Biol Chem. 276:31959–31968.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kawaguchi T, Yamashita Y, Kanamori M, et
al: The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent
growth-inhibitory action of an active fragment of tumstatin in
glioma cells in vitro and in vivo. Cancer Res. 66:11331–11340.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maeshima Y, Sudhakar A, Lively JC, et al:
Tumstatin, an endothelial cell-specific inhibitor of protein
synthesis. Science. 295:140–143. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang GM, Zhang YM, Fu SB, et al: Effects
of cloned tumstatin-related and angiogenesis-inhibitory peptides on
proliferation and apoptosis of endothelial cells. Chin Med J
(Engl). 121:2324–2330. 2008.
|
|
25
|
Shahan TA, Ziaie Z, Pasco S, et al:
Identification of CD47/integrin-associated protein and
alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV
collagen on tumor cells. Cancer Res. 59:4584–4590. 1999.PubMed/NCBI
|
|
26
|
Moreno-Manzano V, Lucio-Cazana J, Konta T,
Nakayama K and Kitamura M: Enhancement of TNF-alpha-induced
apoptosis by immobilized arginine-glycine-aspartate: involvement of
a tyrosine kinase-dependent, MAP kinase-independent mechanism.
Biochem Biophys Res Commun. 277:293–298. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Spector DJ, Halbert DN and Raskas HJ:
Regulation of integrated adenovirus sequences during adenovirus
infection of transformed cells. J Virol. 36:860–871.
1980.PubMed/NCBI
|
|
28
|
Graham FL, Smiley J, Russell WC and Nairn
R: Characteristics of a human cell line transformed by DNA from
human adenovirus type 5. J Gen Virol. 36:59–74. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Silman NJ and Fooks AR: Biophysical
targeting of adenovirus vectors for gene therapy. Curr Opin Mol
Ther. 2:524–531. 2000.
|
|
30
|
He TC, Zhou S, da Costa LT, Yu J, Kinzler
KW and Vogelstein B: A simplified system for generating recombinant
adenoviruses. Pro Natl Acad Sci USA. 95:2509–2514. 1998. View Article : Google Scholar
|
|
31
|
Li YJ, Sun LC, He Y, et al: The anti-tumor
properties of two tumstatin peptide fragments in human gastric
carcinoma. Acta Pharmacol Sin. 30:1307–1315. 2009. View Article : Google Scholar : PubMed/NCBI
|
